Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- What caused the Viking Age?
- Introduction The Scandinavian diaspora of the late eighth to mid-eleventh centuries AD known as the Viking Age was both widespread in scale and profound in impact. Long-range maritime expeditions facilitated a florescence of piracy, trade, migration, conquest and exploration across much of Europe--ultimately extending to western Asia and the...
- Research articles 2008-09-01
- Books received
- EDITIONS AND TRANSLATIONS: Aretino, Pietro. Cortigiana. Carleton Renaissance Plays in Translation 38. Ed. Raymond B. Waddington. Trans. Leonard G. Sbrocchi. Ottawa: Dovehouse Editions, Inc., 2003. 156 pp. append. illus. bibl. n.p. ISBN: 1-895537-70-3. Boccaccio, Giovanni. Famous Women. The I Tatti Renaissance Library 1. Ed. and trans. Virginia Brown....
- Research articles 2004-03-22
Additional Resources
- BioFocus DPI extends ISO certification to Leiden operations
- Mechelen, Belgium; 28 November 2006 - Galapagos NV (Euronext & LSE: GLPG) announced today that its service division BioFocus DPI has extended its International Standards Organization's ISO 9001:2000 certification to cover its Target Discovery operations in...
- Research articles 2006-11-28
- For The Record.(Briefs)(RadioShack will close 18 of its 156 company-owned stores in the Chicago, CEO Jeffrey Leiden of Abbott Labs resigns.)
- RadioShack will close 18 of its 156 company-owned stores in the Chicago area as part of a previously announced restructuring effort. Stores closing in Chicago are at 1730 W. Fullerton and 1600 W. 13th. Abbott Labs said Jeffrey Leiden, 50, is steppi RadioShack will...
- Research articles 2006-03-27
- Crucell Annual General Meeting of Shareholders to be Held in Leiden on June 2, 2006
- Leiden, The Netherlands, May 15, 2006 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: SW CRX) has announced that its Annual General Meeting of Shareholders AGM will be held at the Pieterskerk in Leiden on June 2, 2006, commencing...
- Research articles 2006-05-15
- Crucell to Concentrate Research and Development in Leiden, The Netherlands
- Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) announced today that it will concentrate its research and development (R&D) activities at its Leiden headquarters in The Netherlands. Vaccine manufacturing, regulatory activities, clinical development and vaccine ...
- Research articles 2006-10-30
- Largest solar panel. (Fokker Space's assembly of the largest solar panel in Leiden, the Netherlands)
- Claimed to be the largest solar panel ever built in Europe is currently being assembled by Fokker Space in Leiden. The panel is 14 metres long and 5 metres wide. It will function as an energy source for the European Space Agency's earth observation satellite Envisat-1 ...
- Research articles 1998-07-01
- Extending an ongoing collaboration, Bruker Daltonics formed an advanced research collaboration with the Leiden University Medical Center in the Netherlands for biomarker discovery and clinical proteomies
- Extending an ongoing collaboration, Bruker Daltonics formed an advanced research collaboration with the Leiden University Medical Center in the Netherlands for biomarker discovery and clinical proteomies. The Center acquired two esquire HCT ion traps, a second Ultraflex TOF/TOF and an Apex-Q 9.4 Tesla hybrid Q-q-FT-MS as well as clinical proteomics...
- Research articles 2004-02-15
- ABBOTT LABORATORIES; Rank: 11.(www.abbott.com)(Brief Article)(Company Profile)(Statistical Data Included)
- 100 Abbott Park Road Abbott Park 60064 (847) 937-6100 www.abbott.com CEO: Miles D. White Board members: H. Laurance Fuller, David A. Jones, Jeffrey M. Leiden, Lord Owen, Robert L. Parkinson Jr., Boone Powell Jr.,...
- Research articles 2000-06-07
- Roche Markets PCR Tests.
- Roche Diagnostics (Grenzacherstrasse 124, Postfach Ch-4070, Basel, Switzerland, Tel: +41-61-688-1111, Fax: +41-61-691-9391, Website: roche.com) has launched its new Factor V Leiden Kit and Factor II Prothrombin G20210A Kit for its LightCycler real- Roche Diagnostics (Grenzacherstrasse 124, Postfach Ch-4070, Basel, Switzerland, Tel: +41-61-688-1111, Fax: +41-61-691-9391, Website:...
- Research articles 2004-01-01
- EU Needs Tax Harmonization, Unilever Chairman Declares.
- Europe has been waiting 28 years for a common legal and tax structure for business, and it can't afford to wait any longer, the chairman of Unilever told a conference at Leiden University in Belgium. Europe has been waiting 28 years for a common legal...
- Research articles 1999-01-01
- Crucell Presents Update on Strategy and Operations at Analyst Briefing
- Leiden, The Netherlands, April 27, 2006 -Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: SW CRX) will today present an update on the Company's strategy, research and development programs, product sales and financial outlook in...
- Research articles 2006-04-27
- Crucell announces live webcast of Annual General Meeting of Shareholders
- Leiden, The Netherlands, May 30 2007 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) today announced that there will be a live video webcast of the Annual General Meeting of Shareholders AGM, commencing June 1 at 14:00 hrs CET in Leiden. The webcast will be available...
- Research articles 2007-05-30
- IsoTis adds $2M for work in 'substitution medicine.'
- The financing was led by the existing shareholder, Arias Ventures, and new investors, including 3i of the U.K. and GIMV of Belgium.Headquartered in Bilthoven, IsoTis originally was called Matrix Medical. It was launched in 1996 by Clemens van Blitterswijk, now its CEO, but then professor of biomaterials at the University...
- Research articles 1998-02-01
- Leiden Cabinet Company of Twinsburg, Ohio Honored as Aetna's North Central Region Small Business of the Year
- RICHFIELD, Ohio -- --Aetna to Donate $10,000 to the Cleveland Museum of Natural History in Company's Honor --
- Research articles 2004-10-27
- Crucell to Present at UBS Global Life Sciences Conference, New York, September 28
- Leiden, The Netherlands, September 20, 2006 - Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) has announced that its Chief Financial Officer, Leonard Kruimer, will present at the UBS Global Life Sciences Conference to be held next week (September...
- Research articles 2006-09-20
- Crucell and DSM Biologics Announce Invitrogen as First Partner in PER.C6(R) Vendor Network
- Leiden, The Netherlands, July 10, 2006 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) and technology partner DSM Biologics have announced today that Invitrogen, a leading life...
- Research articles 2006-07-10
- Crucell Announces PER.C6(R) and AdVac(R) Technology License Agreement with Wyeth Pharmaceuticals
- Leiden, The Netherlands, July 30 2007 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) today announced that it has entered into a co-exclusive PER.C6® and Advac® technology license agreement with Wyeth Pharmaceuticals, a division of Wyeth...
- Research articles 2007-07-30
- ABBOTT LABORATORIES.(president/CEO Robert Parkinson retires)(Brief Article)
- ABBOTT LABORATORIES' president and CEO, Robert Parkinson, is retiring, effective January 31. He is being replaced by a three-member leadership structure that took effect August 1. The team consists ... ABBOTT LABORATORIES' president and CEO, Robert Parkinson, is retiring, effective January 31. He is...
- Research articles 2000-08-07
- PHARMING RECIEVES ORPHAN DRUG DESIGNATIONS FOR RHC1INH FROM US FDA
- Leiden, The Netherlands, June 14, 2006. Biotech company Pharming Group NV ("Pharming" or "the Company") (Euronext: PHARM) announced today it has received orphan drug designations for recombinant human C1 inhibitor (rhC1INH) from the Food and Drug Administration FDA. The Company has obtained...
- Research articles 2006-06-14
- << Previous
- page 1 of 1
- Next >>
